Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIO-RAD LABORATORIES, INC.BIO, BIOB · Entity 2247 | Executive Vice President | September 13, 2017 | September 15, 2017 |
| MESA LABORATORIES INC /CO/MLAB · Entity 5221 | Director | September 09, 2026 | September 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIO-RAD LABORATORIES, INC.
Report date September 13, 2017 · Filed September 15, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 564.5691 |
Reported balance
After 2017-09-13 transaction · row 1
1 source rowRow 1 · 2017-09-13 · Sale · Disposed 1,245 · Balance 564.5691 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.18 to 221.24, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.18 to 221.24, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
MESA LABORATORIES INC /CO/
Report date September 09, 2026 · Filed September 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units - 9SEC Table II · derivative / convertible security | Direct | 1,774 |
Reported balance
After 2026-09-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-09 · Grant · Acquired 1,774 · Balance 1,774 F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2: RSUs that vest on September 9, 2027 F3: Not Applicable |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock
F2: RSUs that vest on September 9, 2027
F3: Not Applicable
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 11, 2026 17:57 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 9 · Derivative | 1,774 | $0.00 | $0.00 |
DisclosureSEC source: 0000724004-26-000094 · primary_doc.xml · derivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,774 Underlying: Common Stock · 1,774 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on September 9, 2027 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2026 Filed Aug 17, 2026 21:46 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 8 · Derivative | 2,784 | $0.00 | $0.00 |
DisclosureSEC source: 0000724004-26-000088 · primary_doc.xml · derivative · entry 2 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,784 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vested on August 15, 2026 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2026 Filed Aug 17, 2026 21:46 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 2,784 | $0.00 | $0.00 |
DisclosureSEC source: 0000724004-26-000088 · primary_doc.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 18:02 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 8 · Derivative | 2,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001197710-25-000006 · primary_doc.xml · derivative · entry 3 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,784 Underlying: Common Stock · 2,784 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs that vest on August 15, 2026 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 18:02 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 7 · Derivative | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001197710-25-000006 · primary_doc.xml · derivative · entry 2 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vested on August 15, 2025 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2025 Filed Aug 18, 2025 18:02 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001197710-25-000006 · primary_doc.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2024 Filed Sep 6, 2024 15:28 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 6 · Derivative | 1,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-24-000021 · primary_doc.xml · derivative · entry 2 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,074 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vested on September 1, 2024 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 01, 2024 Filed Sep 6, 2024 15:28 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-24-000021 · primary_doc.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 16:01 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 7 · Derivative | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-24-000018 · primary_doc.xml · derivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,404 Underlying: Common Stock · 1,404 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2025 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 16:26 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 6 · Derivative | 1,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000034 · primary_doc.xml · derivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,074 Underlying: Common Stock · 1,074 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on September 1, 2024 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 18:03 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 5 · Derivative | 754 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000021 · primary_doc.xml · derivative · entry 2 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 754 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2023 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 18:03 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 754 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000021 · primary_doc.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 14:00 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 230 | $174.98 | $40,244.25 |
DisclosureSEC source: 0001228924-22-000044 · primary_doc.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 957 Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 16:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 4 · Derivative | 431 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000036 · primary_doc.xml · derivative · entry 2 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 431 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Vested RSUs for Board of Director Services F3 · derivative.expiration_date: Not applicable Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 16:37 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 431 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000036 · primary_doc.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 18, 2022 19:58 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 5 · Derivative | 754 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000030 · primary_doc.xml · derivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 754 Underlying: Common Stock · 754 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2023 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 21:32 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 4 · Derivative | 431 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000063 · primary_doc.xml · derivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431 Underlying: Common Stock · 431 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on September 1, 2022 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2021 Filed Aug 16, 2021 17:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 3 · Derivative | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000053 · primary_doc.xml · derivative · entry 2 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 308 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vested 100% on August 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2021 Filed Aug 16, 2021 17:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000053 · primary_doc.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 18:31 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 2 · Derivative | 194 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000031 · primary_doc.xml · derivative · entry 2 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 194 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Represents Restricted Stock Units granted for the conversion of cash compensation for Board of Director services for the twelve months ended June 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 18:31 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 194 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000031 · primary_doc.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 14:56 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000031 · primary_doc.xml · derivative · entry 3 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 254 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs that vested on November 15, 2020 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 14:56 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Unit - 3 · Derivative | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000031 · primary_doc.xml · derivative · entry 2 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308 Underlying: Common Stock · 308 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 14:56 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000031 · primary_doc.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Represents stock from RSUs that vested on November 15, 2020 Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 15:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 2 · Derivative | 194 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000016 · primary_doc.xml · derivative · entry 2 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194 Underlying: Common Stock · 194 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · shares: Represents RSUs for the conversion of cash compensation for Board of Director services for Fiscal Year 2021 F5 · derivative.exercise_date: RSUs that cliff vest on June 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 15:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 1 · Derivative | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000016 · primary_doc.xml · derivative · entry 1 Hall Shannon · CIK 0001621222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254 Underlying: Common Stock · 254 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on November 15, 2020 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 00:27 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 1,245 | $221.20 | $275,390.14 |
DisclosureSEC source: 0001652252-17-000108 · edgar.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564.5691 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.18 to 221.24, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:23 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 240 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000100 · edgar.xml · derivative · entry 3 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:23 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 91 | $218.04 | $19,841.64 |
DisclosureSEC source: 0001652252-17-000100 · edgar.xml · nonDerivative · entry 2 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,809.5691 Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 22:23 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000100 · edgar.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900.5691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:22 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000080 · edgar.xml · derivative · entry 7 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2016. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:22 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 240 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000080 · edgar.xml · derivative · entry 6 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240 Underlying: Bio-Rad A Common Stock · 240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 11, 2014. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:22 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 317 | $218.86 | $69,378.62 |
DisclosureSEC source: 0001652252-17-000080 · edgar.xml · nonDerivative · entry 4 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,660.5691 Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 18:22 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 840 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000080 · edgar.xml · nonDerivative · entry 3 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,977.5691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 10, 2017 Filed Sep 12, 2017 18:22 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 240 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000080 · edgar.xml · derivative · entry 5 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480 Underlying: Bio-Rad A Common Stock · 240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 10, 2015. Read SEC document |
| September 10, 2017 Filed Sep 12, 2017 18:22 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 91 | $218.42 | $19,876.22 |
DisclosureSEC source: 0001652252-17-000080 · edgar.xml · nonDerivative · entry 2 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,137.5691 Read SEC document |
| September 10, 2017 Filed Sep 12, 2017 18:22 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000080 · edgar.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,228.5691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 20:12 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000064 · edgar.xml · derivative · entry 3 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 7, 2017. F3 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 7, 2017. Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 20:12 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 226 | $215.44 | $48,689.44 |
DisclosureSEC source: 0001652252-17-000064 · edgar.xml · nonDerivative · entry 2 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 988.5691 Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 20:12 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000064 · edgar.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,214.5691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 23:03 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $215.98 | $0.00 |
DisclosureSEC source: 0001652252-17-000043 · edgar.xml · derivative · entry 3 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Bio-Rad A Common Stock · 3,000 shares Expires 2027-09-05 F4 · derivative.exercise_date: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 23:03 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | GrantRestricted Stock Units · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-17-000043 · edgar.xml · derivative · entry 2 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Bio-Rad A Common Stock · 3,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 20:18 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 900 | $222.65 | $200,386.53 |
DisclosureSEC source: 0001652252-17-000035 · edgar.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560.1019 F1 · balance_after: Includes 69.9966 shares acquired under the Bio-Rad Laboratories employee stock purchase plan on March 31, 2017. Read SEC document |
| November 07, 2016 Filed Nov 8, 2016 23:45 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 84 | $165.62 | $13,912.08 |
DisclosureSEC source: 0001652252-16-000142 · edgar.xml · nonDerivative · entry 2 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,390.1053 F3 · shares: Sold by the Issuer on behalf of the Reporting Person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 23:45 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 220 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000142 · edgar.xml · derivative · entry 3 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 220 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning November 4, 2012. F5 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning November 4, 2012. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 23:45 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 220 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000142 · edgar.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,474.1053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 13.0933 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 9/30/16. Read SEC document |
| September 13, 2016 Filed Sep 14, 2016 19:31 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 92 | $158.08 | $14,543.28 |
DisclosureSEC source: 0001652252-16-000116 · edgar.xml · nonDerivative · entry 2 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,241.012 F2 · shares: Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:02 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | SaleBio-Rad A Common Stock | 414 | $155.02 | $64,177.00 |
DisclosureSEC source: 0001652252-16-000106 · edgar.xml · nonDerivative · entry 3 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,093.012 F2 · shares: Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.0162 to $155.0174, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 19:31 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 240 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000116 · edgar.xml · derivative · entry 3 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240 Underlying: Bio-Rad A Common Stock · 240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. F4 · derivative.expiration_date: The restricted stock units vest in five equal annual installments beginning September 12, 2013. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 19:31 UTC | BIO-RAD LABORATORIES, INC. BIO, BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001652252-16-000116 · edgar.xml · nonDerivative · entry 1 Hall Shannon · CIK 0001621222 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,333.012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.